Condition: Massive Rotator Cuff Tear · Sponsor: Voll Medical Technologies Ltd.
The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Assuta Ashdod Hospital | Ashdod, Israel | Recruiting |
| Ichilov (Sourasky Medical Center) | Tel Aviv, Israel | Not Yet Recruiting |
| Humanitas Gavazzeni Castelli | Bergamo, Bergamo, Italy | Not Yet Recruiting |
| Istituto Ortopedico Rizzoli | Bologna, Bologna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07208448